New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 9, 2014
07:23 EDTBIIBBiogen price target raised to $375 from $325 at RBC Capital
RBC Capital increased its price target on Biogen as the firm predicts the company will report stronger than expected 2H14 results and thinks that upcoming positive data on key drugs could push the stock higher. The firm recommends that investors own the stock ahead of data expected to be released at the end of this year and in spring 2015. It keeps an Outperform rating on the shares.
News For BIIB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 15, 2015
07:29 EDTBIIBOutlook for Biogen trials positive , says RBC Capital
Subscribe for More Information
January 14, 2015
07:05 EDTBIIBIsis Pharmaceuticals earns $7M from Biogen for advancing muscular atrophy study
Subscribe for More Information
January 13, 2015
13:09 EDTBIIBBiogen CEO says company has strengthened R&D, to stay active in M&A
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use